Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 1
1964 2
1965 1
1966 3
1967 3
1968 4
1970 4
1971 7
1972 2
1973 2
1974 3
1975 2
1976 2
1977 10
1978 10
1979 7
1980 11
1981 15
1982 18
1983 23
1984 29
1985 23
1986 29
1987 44
1988 50
1989 47
1990 43
1991 52
1992 56
1993 75
1994 69
1995 75
1996 96
1997 126
1998 147
1999 225
2000 275
2001 281
2002 335
2003 357
2004 439
2005 482
2006 563
2007 648
2008 713
2009 828
2010 986
2011 1254
2012 1365
2013 1412
2014 1490
2015 1612
2016 1503
2017 1593
2018 1606
2019 1677
2020 1909
2021 2012
2022 1778
2023 1731
2024 1809
2025 1692
2026 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,308 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer.
Cortés J, Punie K, Barrios C, Hurvitz SA, Schneeweiss A, Sohn J, Tokunaga E, Brufsky A, Park YH, Xu B, Hegg R, Oliveira M, Fabi A, Vaksman N, Valdez T, Zhang X, Lai C, Tolaney SM; ASCENT-03 Clinical Trial Investigators. Cortés J, et al. Among authors: park yh. N Engl J Med. 2025 Nov 13;393(19):1912-1925. doi: 10.1056/NEJMoa2511734. Epub 2025 Oct 19. N Engl J Med. 2025. PMID: 41124233 Clinical Trial.
Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study.
Shitara K, Rha SY, Wyrwicz L, Oshima T, Karaseva N, Osipov M, Yasui H, Yabusaki H, Afanasyev S, Park YK, Al-Batran SE, Yoshikawa T, Yanez P, Pietrantonio F, Lonardi S, Fang X, Guan Y, Valderrama A, Leconte P, Bhagia P, Bang YJ; KEYNOTE-585 Investigators. Shitara K, et al. Among authors: park yk. J Clin Oncol. 2025 Oct 10;43(29):3152-3159. doi: 10.1200/JCO-25-00486. Epub 2025 Aug 19. J Clin Oncol. 2025. PMID: 40829093 Clinical Trial.
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.
Tolaney SM, Jiang Z, Zhang Q, Barroso-Sousa R, Park YH, Rimawi MF, Saura C, Schneeweiss A, Toi M, Chae YS, Kemal Y, Chaudhari M, Şendur MAN, Yamashita T, Casalnuovo M, Danso MA, Liu J, Shetty J, Herbolsheimer P, Loibl S; DESTINY-Breast09 Trial Investigators. Tolaney SM, et al. Among authors: park yh. N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMoa2508668. Online ahead of print. N Engl J Med. 2025. PMID: 41160818
Spatially patterned kidney assembloids recapitulate progenitor self-assembly and enable high-fidelity in vivo disease modeling.
Huang B, Medina P, He J, Zeng Z, Kim S, Romo J, Koppitch K, Zhang CC, Gyarmati G, Park Y, Bohovyk R, N'Guetta PY, Guo J, Ma T, Schreiber ME, Xu C, Pham J, Parvez RK, Su J, Xia MW, Liu Z, Perin L, El-Nachef D, Murry CE, Kumar S, O'Brien L, Zimmerman KA, Ichida J, Lindström NO, Pastor-Soler NM, Hallows KR, Staruschenko A, Peti-Peterdi J, Jiang C, McMahon AP, Li Z. Huang B, et al. Among authors: park y. Cell Stem Cell. 2025 Oct 2;32(10):1614-1633.e13. doi: 10.1016/j.stem.2025.08.013. Epub 2025 Sep 17. Cell Stem Cell. 2025. PMID: 40967224
Whole-genome landscapes of 1,364 breast cancers.
Kim R, Yu J, Lim J, Oh BB, Nam SJ, Kim SW, Lee JE, Chae BJ, Kim JY, Park GE, Kang BJ, Paik PS, Bae SY, Yoon CI, Lee YJ, Kim D, Shin K, Lee JE, Kang J, Lee A, Connolly-Strong E, Lee S, Lee BR, Lee Y, Yi KJ, Kwon YO, Chun IH, Park J, Kim J, Choi C, Shin JY, Lee H, Kim M, Park H, Jeong I, Yi B, Lee WC, Lee JS, Park WC, Kim SH, Choi YL, Lee J, Ju YS, Park YH. Kim R, et al. Among authors: park yh. Nature. 2025 Dec 3. doi: 10.1038/s41586-025-09812-3. Online ahead of print. Nature. 2025. PMID: 41339552
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.
Modi S, Jacot W, Iwata H, Park YH, Vidal Losada M, Li W, Tsurutani J, Ueno NT, Zaman K, Prat A, Papazisis K, Rugo HS, Yamashita T, Harbeck N, Im SA, De Laurentiis M, Pierga JY, Wang X, Gombos A, Tokunaga E, Orbegoso Aguilar C, Yung L, Xiao F, Cheng Y, Cameron D. Modi S, et al. Among authors: park yh. Nat Med. 2025 Dec;31(12):4205-4213. doi: 10.1038/s41591-025-03981-4. Epub 2025 Oct 8. Nat Med. 2025. PMID: 41062831 Clinical Trial.
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
Hecht JR, Park YS, Tabernero J, Lee MA, Lee S, Virgili AC, Van den Eynde M, Fontana E, Fakih M, Asghari G, So J, Stein A, Dubreuil O, Bodnar L, He CS, Wang G, Smith R, Eng C, Saeed A; STELLAR-303 study investigators. Hecht JR, et al. Among authors: park ys. Lancet. 2025 Nov 15;406(10517):2360-2370. doi: 10.1016/S0140-6736(25)02025-2. Epub 2025 Oct 20. Lancet. 2025. PMID: 41130252 Clinical Trial.
Myeloid Cells in Acute Kidney Injury.
Park Y, Zimmerman KA, Miller SJ. Park Y, et al. Semin Nephrol. 2025 Nov;45(6):151666. doi: 10.1016/j.semnephrol.2025.151666. Epub 2025 Sep 14. Semin Nephrol. 2025. PMID: 40947392 Review.
Digital ulcerations in amyopathic dermatomyositis.
Cho HI, Han JH, Park Y. Cho HI, et al. Among authors: park y. Korean J Intern Med. 2025 Dec 4. doi: 10.3904/kjim.2025.023. Online ahead of print. Korean J Intern Med. 2025. PMID: 41340404 Free article. No abstract available.
Intravascular Imaging-Guided PCI vs Coronary Artery Bypass Grafting for Left Main or 3-Vessel Disease.
Lee SY, Cho YH, Sung K, Kim WS, Lee SJ, Kwon W, Lee JY, Lee SH, Shin D, Lee SY, Kim SM, Yun KH, Cho JY, Kim CJ, Ahn HS, Nam CW, Yoon HJ, Park YH, Lee WS, Choi KH, Park TK, Yang JH, Choi SH, Gwon HC, Song YB, Hahn JY, Jeong DS, Lee JM. Lee SY, et al. Among authors: park yh. JACC Cardiovasc Interv. 2025 Sep 8;18(17):2077-2088. doi: 10.1016/j.jcin.2025.06.034. Epub 2025 Aug 27. JACC Cardiovasc Interv. 2025. PMID: 40864021 Clinical Trial.
28,308 results
You have reached the last available page of results. Please see the User Guide for more information.